136 related articles for article (PubMed ID: 24370558)
1. Concurrent pharmacological modification of cannabinoid-1 and glucagon-like peptide-1 receptor activity affects feeding behavior and body weight in rats fed a free-choice, high-carbohydrate diet.
Radziszewska E; Wolak M; Bojanowska E
Behav Pharmacol; 2014 Feb; 25(1):53-60. PubMed ID: 24370558
[TBL] [Abstract][Full Text] [Related]
2. Effects of glucagon-like peptide-1 receptor stimulation and blockade on food consumption and body weight in rats treated with a cannabinoid CB1 receptor agonist WIN 55,212-2.
Radziszewska E; Bojanowska E
Med Sci Monit Basic Res; 2013 Jan; 19():6-11. PubMed ID: 23291632
[TBL] [Abstract][Full Text] [Related]
3. Combined stimulation of glucagon-like peptide-1 receptor and inhibition of cannabinoid CB1 receptor act synergistically to reduce food intake and body weight in the rat.
Bojanowska E; Radziszewska E
J Physiol Pharmacol; 2011 Aug; 62(4):395-402. PubMed ID: 22100840
[TBL] [Abstract][Full Text] [Related]
4. The effects of leptin in combination with a cannabinoid receptor 1 antagonist, AM 251, or cannabidiol on food intake and body weight in rats fed a high-fat or a free-choice high sugar diet.
Wierucka-Rybak M; Wolak M; Bojanowska E
J Physiol Pharmacol; 2014 Aug; 65(4):487-96. PubMed ID: 25179081
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid receptor 1 antagonist treatment induces glucagon release and shows an additive therapeutic effect with GLP-1 agonist in diet-induced obese mice.
Patel KN; Joharapurkar AA; Patel V; Kshirsagar SG; Bahekar R; Srivastava BK; Jain MR
Can J Physiol Pharmacol; 2014 Dec; 92(12):975-83. PubMed ID: 25361428
[TBL] [Abstract][Full Text] [Related]
6. Maintenance on a high-fat diet impairs the anorexic response to glucagon-like-peptide-1 receptor activation.
Williams DL; Hyvarinen N; Lilly N; Kay K; Dossat A; Parise E; Torregrossa AM
Physiol Behav; 2011 Jul; 103(5):557-64. PubMed ID: 21515295
[TBL] [Abstract][Full Text] [Related]
7. A glucagon-like peptide-1 receptor agonist and an antagonist modify macronutrient selection by rats.
Peters CT; Choi YH; Brubaker PL; Anderson GH
J Nutr; 2001 Aug; 131(8):2164-70. PubMed ID: 11481412
[TBL] [Abstract][Full Text] [Related]
8. Colocalization of glucagon-like peptide-1 (GLP-1) receptors, glucose transporter GLUT-2, and glucokinase mRNAs in rat hypothalamic cells: evidence for a role of GLP-1 receptor agonists as an inhibitory signal for food and water intake.
Navarro M; Rodriquez de Fonseca F; Alvarez E; Chowen JA; Zueco JA; Gomez R; Eng J; Blázquez E
J Neurochem; 1996 Nov; 67(5):1982-91. PubMed ID: 8863504
[TBL] [Abstract][Full Text] [Related]
9. Combination of obesity and high-fat feeding diminishes sensitivity to GLP-1R agonist exendin-4.
Duca FA; Sakar Y; Covasa M
Diabetes; 2013 Jul; 62(7):2410-5. PubMed ID: 23423571
[TBL] [Abstract][Full Text] [Related]
10. Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure.
Baggio LL; Huang Q; Brown TJ; Drucker DJ
Gastroenterology; 2004 Aug; 127(2):546-58. PubMed ID: 15300587
[TBL] [Abstract][Full Text] [Related]
11. The inverse agonist of CB1 receptor SR141716 blocks compulsive eating of palatable food.
Dore R; Valenza M; Wang X; Rice KC; Sabino V; Cottone P
Addict Biol; 2014 Sep; 19(5):849-61. PubMed ID: 23587012
[TBL] [Abstract][Full Text] [Related]
12. Roux-en-Y gastric bypass in rats increases sucrose taste-related motivated behavior independent of pharmacological GLP-1-receptor modulation.
Mathes CM; Bueter M; Smith KR; Lutz TA; le Roux CW; Spector AC
Am J Physiol Regul Integr Comp Physiol; 2012 Mar; 302(6):R751-67. PubMed ID: 22170618
[TBL] [Abstract][Full Text] [Related]
13. Delta9-THC induced hyperphagia and tolerance assessment: interactions between the CB1 receptor agonist delta9-THC and the CB1 receptor antagonist SR-141716 (rimonabant) in rats.
Järbe TU; DiPatrizio NV
Behav Pharmacol; 2005 Sep; 16(5-6):373-80. PubMed ID: 16148441
[TBL] [Abstract][Full Text] [Related]
14. A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents.
Cluny NL; Vemuri VK; Chambers AP; Limebeer CL; Bedard H; Wood JT; Lutz B; Zimmer A; Parker LA; Makriyannis A; Sharkey KA
Br J Pharmacol; 2010 Oct; 161(3):629-42. PubMed ID: 20880401
[TBL] [Abstract][Full Text] [Related]
15. Acute peripheral GLP-1 receptor agonism or antagonism does not alter energy expenditure in rats after Roux-en-Y gastric bypass.
Abegg K; Schiesser M; Lutz TA; Bueter M
Physiol Behav; 2013 Sep; 121():70-8. PubMed ID: 23562866
[TBL] [Abstract][Full Text] [Related]
16. High-fat diet changes the temporal profile of GLP-1 receptor-mediated hypophagia in rats.
Mul JD; Begg DP; Barrera JG; Li B; Matter EK; D'Alessio DA; Woods SC; Seeley RJ; Sandoval DA
Am J Physiol Regul Integr Comp Physiol; 2013 Jul; 305(1):R68-77. PubMed ID: 23616105
[TBL] [Abstract][Full Text] [Related]
17. The peptide hemopressin acts through CB1 cannabinoid receptors to reduce food intake in rats and mice.
Dodd GT; Mancini G; Lutz B; Luckman SM
J Neurosci; 2010 May; 30(21):7369-76. PubMed ID: 20505104
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking.
Gamaleddin I; Wertheim C; Zhu AZ; Coen KM; Vemuri K; Makryannis A; Goldberg SR; Le Foll B
Addict Biol; 2012 Jan; 17(1):47-61. PubMed ID: 21521420
[TBL] [Abstract][Full Text] [Related]
19. Hindbrain leptin and glucagon-like-peptide-1 receptor signaling interact to suppress food intake in an additive manner.
Zhao S; Kanoski SE; Yan J; Grill HJ; Hayes MR
Int J Obes (Lond); 2012 Dec; 36(12):1522-8. PubMed ID: 22249232
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid subtype-2 receptors modulate the antihyperalgesic effect of WIN 55,212-2 in rats with neuropathic spinal cord injury pain.
Ahmed MM; Rajpal S; Sweeney C; Gerovac TA; Allcock B; McChesney S; Patel AU; Tilghman JI; Miranpuri GS; Resnick DK
Spine J; 2010 Dec; 10(12):1049-54. PubMed ID: 20920894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
